IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM® Day on Wednesday, August 16, 2023. The celebration recognizes the ...

Allergan's latest hyaluronic acid injectable gel uses the patented VYCROSS® technology and is specifically formulated to restore and create volume(1) According to research 51% (n=1,707) of people want ...

IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM ® Day on Wednesday, August 16, 2023. The celebration recognizes the ...

IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers to experience the JUVÉDERM ® difference. The JUVÉDERM ® Collection of Fillers is ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX(R) Cosmetic (Botulinum Toxin Type A), today announced it is launching its 'next-generation' hyaluronic acid dermal filler ...

An icon in the shape of a calendar. A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". Allē Double Point Promotion Encourages ...

DUBLIN, Oct. 3, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today the launch of a new JUVÉDERM ® advertising campaign created to empower the next generation of consumers to "JUVÉDERM ® IT.

Research highlights 94% of people want to improve facial skin quality 1*, with deep hydration valued across all ages worldwide 2. SKINVIVE ® is the longest lasting hydrating injectable on the market, ...

Allergan Announces FDA Approval of Label Extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus IRVINE, Calif. -- Allergan, Inc., the maker of BOTOX® Cosmetic (Botulinum Toxin Type A), today announced ...

It’s all about the lips in Allergan’s latest Juvederm campaign. In its first consumer effort focused on lip treatments, Allergan looks to especially target millennials with a natural—but ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX ® Cosmetic (Botulinum Toxin Type A), today announced nationwide availability of its ‘next-generation’ hyaluronic acid ...